₹968.4
+2.7% today
· 30d +4.13%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for JUBLPHARMA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹2229 Cr
+17.29% YoY
NET PROFIT
₹56 Cr
-44.98% YoY
OPM
11.91%
-3.86pp YoY
EPS
₹3.57
PE 44.54
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.5% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
ML Forward Growth Predictions 🔒
53
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
UNDERPERFORMER
20
Valuation
FAIR
40
Growth
STEADY
53
Profitability
DECENT
58
Technicals
NEUTRAL
55
Risk
LOW
90
Key Stats
TTM PE
44.54
P/B
2.21
52W HIGH
₹1183.0
OFF HIGH
-18.14%
DIV YIELD
0.52%
MKT CAP
₹15268 Cr
◉ Active Signals
MACDNeutral3.3431
RSI(14)Neutral53.92
Street Consensus
2 analysts₹1088.5
mean target
Low ₹850.0Now ₹968.4High ₹1327.0
⧉ Strategy Fit 🔒